Dr. Varela is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2415 N Orange Ave
Ste 601
Orlando, FL 32804Phone+1 407-303-2070Fax+1 407-303-2071- Is this information wrong?
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 2010 - 2013
- Medical University of South CarolinaClass of 2010
Certifications & Licensure
- FL State Medical License 2017 - 2026
- MA State Medical License 2022 - 2024
- SC State Medical License 2015 - 2019
- MD State Medical License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Immune checkpoint blockade in hematological malignancies: current state and future potential.Prateek Pophali, Juan Carlos Varela, Jacalyn Rosenblatt> ;Frontiers in Oncology. 2024 Jan 1
- Evaluation of different pharmacokinetically guided IV busulfan exposure ranges on adult patient outcomes after hematopoietic stem cell transplantation.Nahir Rivera-Robles, Cory Mical Edgar, Courtney Paige Mcvey, Fanchao Yi, Sarfraz Ahmad, Rushang D Patel, Juan Carlos Varela, Shahram Mori, Mengni Guo> ;Annals of Hematology. 2023 Jan 1
- 3 citationsCryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host ...Pamela Clark, Sarfraz Ahmad, Rushang Patel, Juan Carlos Varela, Mengni Guo, Shahram Mori, Jieying Liu> ;International Journal of Hematology. 2023 Mar 1
- Join now to see all
Journal Articles
- Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma (L-NN-MCL) with P53 Gene Re-arrangement/Mutation Is Highly Responsive to Rituximab/Ibrutinib Combination TherapyShahram Mori, Juan Varela, Steven C Goldstein, Daniel O Persky, Clinical Lymphoma, Myeloma, & Leukemia
Authored Content
- Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma (L-NN-MCL) with P53 Gene Re-arrangement/Mutation Is Highly Responsive to Rituximab/Ibrutinib Combination TherapyNovember 2018
Press Mentions
- AdventHealth Launches First-of-Its-Kind Immunotherapy Treatment, Clinical Trial for Specific Blood Cancer PatientsJune 12th, 2020
- Contigo Fund Gets $150,000 Grant from GileadOctober 17th, 2019
- Vital £50,000 Boost for Dementia Research at St Andrews UniversitySeptember 30th, 2019
- Join now to see all
Hospital Affiliations
- AdventHealth OrlandoOrlando, Florida
- Orlando Health Orlando Regional Medical CenterOrlando, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: